SCIENCE

Research is where every Stellar formula starts.

Stellar is built around a single discipline: published clinical research drives the formula, not the other way around. This page documents the principles that govern how research becomes product.

FOUR OPERATING PRINCIPLES

How research becomes formula.

The science discipline isn't a marketing claim. It's an operating method that gates what ships.

01 · PRIMARY

Peer-reviewed first.

We anchor to peer-reviewed clinical literature over secondary sources. Mechanism-of-action research is supporting context, not substitute evidence.

02 · DOSED

Dose is research-anchored.

Each ingredient's dose maps to the dose range studied in published clinical research — not to arbitrary RDV targets.

03 · OPTIMIZED

AI screens combinations against the literature.

Models cross-reference candidate combinations against published data — flagging conflicts, redundancies, and dose-rationale gaps before manufacturing.

04 · PUBLISHED

Per-claim source list.

Each structure/function statement on a Stellar product maps to a published reference. The list is inspectable rather than walled-off.

ON AI-FORMULATION

WHAT 'AI-FORMULATED' MEANS HERE

AI screens published research. It does not invent doses.

'AI-formulated' is one of the more abused phrases in the supplement category. At Stellar it has a specific operating meaning: large-corpus models read across published clinical research to surface ingredient combinations, dose-response relationships, and interaction signals that a human researcher would take materially longer to map.

It is a literature-screening discipline — not a generation discipline.

Every dose that ships is justified against the same published source set the AI consulted. The methodology is reviewed by evidence review, the lab issues the COA, and the formula is auditable end-to-end. AI accelerates the literature pass; it does not bypass it.

SHILAJIT MATRIX+

Every active. Every dose. The reasoning.

Tap any active to see why we chose the dose, the mechanism, and the studies the choice is anchored to. Amounts are per 2-capsule serving.

10 ACTIVES · TAP TO INSPECT
  • 01 Shilajit fulvic complex 500mg

    Why this dose

    500 mg is the higher of the two doses in the human strength RCT (Keller 2019), the dose at which an effect was reported; that extract was standardized differently from ours. Our extract is standardized to 70% fulvic acid, verified per lot on the Certificate of Analysis.

    Mechanism

    Supports cellular energy production by contributing fulvic acid and dibenzo-α-pyrones implicated in CoQ10 transport.

  • 02 Urolithin A 250mg

    Why this dose

    250 mg is inside the studied 10–1,000 mg/day range; the muscle and mitochondrial-gene outcomes were reported at 500–1,000 mg/day. Stated plainly.

    Mechanism

    Activates mitophagy — the cell's recycling process for damaged mitochondria.

  • 03 Nicotinamide Riboside 150mg

    Why this dose

    Single doses of 100–1,000 mg raised the blood NAD+ metabolome dose-dependently; 150 mg is an NAD+-precursor amount inside that tested range, within a combined formula.

    Mechanism

    Serves as a precursor for NAD+ — a cofactor required by sirtuins and mitochondrial enzymes.

  • 04 CoQ10 (ubiquinol) 200mg

    Why this dose

    200 mg per day of the reduced ubiquinol form sits in the human bioenergetic dose range; ubiquinol is selected for higher bioavailability than ubiquinone.

    Mechanism

    Electron transport in the mitochondrial respiratory chain.

  • 05 PQQ 20mg

    Why this dose

    Held at the dose where a 2013 human study observed inflammation and mitochondrial-related metabolism shifts.

    Mechanism

    Cofactor implicated in mitochondrial biogenesis; reduces mitochondrial oxidative stress in vitro.

  • 06 Astaxanthin 12mg

    Why this dose

    Dosed at 12 mg, toward the upper end of the 2–12 mg/day range used in human antioxidant trials; the exact per-lot amount is disclosed on the Certificate of Analysis.

    Mechanism

    Lipid-phase antioxidant with reported activity in cell membranes and mitochondrial inner membrane.

  • 07 Alpha-Lipoic Acid (R-isomer) 125mg

    Why this dose

    Human ALA studies commonly use higher amounts (roughly 200–2,400 mg/day; PK studies used 500–600 mg). 125 mg is a supporting cofactor amount inside a combined formula; we do not claim it reproduces those higher-dose results.

    Mechanism

    Cofactor for mitochondrial enzymes; recycles other antioxidants in vivo.

  • 08 Black pepper extract (BioPerine®) 10mg

    Why this dose

    Dosed at 10 mg (standardized to 95% piperine), the amount used in absorption-enhancement studies for co-administered actives; the exact per-lot amount is disclosed on the Certificate of Analysis.

    Mechanism

    Inhibits intestinal glucuronidation; can increase bioavailability of co-administered ingredients.

  • 09 Apigenin 15mg

    Why this dose

    Included for its role in the NAD+ pathway. In cell and animal studies apigenin inhibits CD38, the main NAD+-consuming enzyme, which is why it sits beside nicotinamide riboside; the evidence is preclinical and is presented as rationale, not an outcome.

    Mechanism

    A chamomile/parsley flavone studied as a CD38 inhibitor in preclinical models.

  • 10 Spermidine (wheat germ) 5mg

    Why this dose

    A polyamine studied alongside urolithin A for complementary autophagy and mitophagy roles. Stated plainly: controlled human pharmacokinetic work found 15 mg/day did not raise plasma spermidine and 40 mg/day was well tolerated; our amount is below both. Contains wheat.

    Mechanism

    Induces autophagy — the cell's recycling system.

READ THE WORK

The methodology is inspectable.

Read the full methodology framework, browse research by ingredient, or jump straight to a formula.